Sep 08, 2017 11:30 am UTC| Business
GAITHERSBURG, Md., Sept. 08, 2017 -- OpGen, Inc. (NASDAQ:OPGN) today announced that the Company presented study results on the company’s new rapid test in development, the Acuitas® AMR Gene Panel u5.47, and the Acuitas...
Stemline Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
Sep 08, 2017 11:30 am UTC| Business
NEW YORK, Sept. 08, 2017 -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today that Ivan Bergstein, M.D.,...
Sep 08, 2017 11:30 am UTC| Business
CAMBRIDGE, Mass. and EXTON, Pa., Sept. 08, 2017 -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a clinical-stage biopharmaceutical company developing toll-like receptor and RNA therapeutics for patients with cancer and...
Sep 08, 2017 11:00 am UTC| Business
Newark, NJ, Sept. 08, 2017 -- BACKGROUND: Dr. Angela T. Alistar, Medical Director, GI Medical Oncology at Atlantic Health System Cancer Care, will lead a poster presentation at the 2017 European Society for Medical...
FS Bancorp, Inc. Announces Pricing of Upsized Public Offering of Common Stock
Sep 08, 2017 11:00 am UTC| Business
MOUNTLAKE TERRACE, Wash., Sept. 08, 2017 -- FS Bancorp, Inc. (NASDAQ:FSBW) (the “Company”), the holding company for 1st Security Bank of Washington (the “Bank”), today announced the pricing of an upsized underwritten...
Plug Power Named to Internationally Respected Hydrogen Council as Supporting Member
Sep 08, 2017 11:00 am UTC| Business
LATHAM, N.Y., Sept. 08, 2017 -- Plug Power Inc. (NASDAQ:PLUG), a leader in providing energy solutions that change the way the world moves, has been named to the Hydrogen Council as a supporting committee member. The...
Sep 08, 2017 11:00 am UTC| Business
Top-line Phase 1 Selinexor Data in Combination with Chemotherapy Show Encouraging Early Efficacy in Patients with Ovarian and Endometrial Cancers Top-line Phase 1 KPT-9274 Data Show a Manageable Safety Profile and Early...